Those of childbearing age more doubtful about safety of flu, COVID-19 vaccines during pregnancy
With a vaccine on the horizon for RSV that is designed to protect pregnant people and their fetuses, new survey research finds that women of childbearing age are more doubtful than other adults about the safety of existing, recommended vaccines.
Research from the Annenberg Public Policy Center (APPC) shows that higher percentages of women of childbearing age (18 to 49 years old) do not think that vaccination against COVID-19 and the flu during pregnancy is safe, when compared with women age 50 and older and all adult men. The survey findings are contained in APPC’s second Annenberg Science and Public Health (ASAPH) Knowledge Monitor, which is based on 10 waves of a nationally representative panel survey of U.S. adults, with the most recent wave conducted with more than 1,600 U.S. adults in January 2023.
Although a majority of women of childbearing age know that the seasonal flu vaccine “is safe for pregnant women,” 17% of women of childbearing age incorrectly think that is false. Doubts that the vaccine is safe for pregnant women are held by a much larger percentage of women of childbearing age than women 50 years old and older or adult men.
This trend is even more pronounced with the COVID-19 vaccine. As seen in a prior wave of the survey, in August 2022, just over 4 in 10 women of childbearing age know that COVID-19 vaccination during pregnancy is safe and effective. But nearly a third of women of childbearing age incorrectly think it is false to say that COVID-19 vaccination during pregnancy is safe and effective. Many more women of childbearing age doubt the safety and effectiveness of COVID-19 vaccination during pregnancy than older women or adult men.
“Because the COVID and flu vaccines help protect both those who are pregnant and their infants, dispatching misconceptions about them should be a public health priority,” says Kathleen Hall Jamieson, director of the Annenberg Public Policy Center. “That women of childbearing age are showing doubt in the safety of current, authorized vaccines is worrisome.”
The report finds differences among women of childbearing age depending on vaccination status.The COVID-19 vaccination during pregnancy is considered safe and effective by 59% of women of childbearing age who report having had the primary series of COVID-19 vaccine shots, but only 8% of those who did not report taking COVID vaccines. Large numbers of people—especially, women age 50 and older—are not sure if the two vaccines are safe during pregnancy. Among women 50 and older, 39% are not sure if the COVID-19 vaccine is safe and effective during pregnancy, and over half are not sure if the flu shot is safe for pregnant women. The Centers for Disease Control and Prevention (CDC) recommends both the flu shot and a COVID-19 vaccine for pregnant people.
In Senegal, the ambitious Dakar Greenbelt project seeks to create an extensive network of ecological infrastructure in and around the city to sustainably address environmental concerns and enhance urban life. With support from David Gouverneur and Ellen Neises, Ph.D. candidate Rob Levinthal in the Weitzman School of Design led two courses that included a field trip to Dakar, that culminated in students presenting their visions for parts of the Greenbelt.
From a desert to an oasis: Penn engages in ambitious greening effort in the Sahel
Students from the Weitzman School of Design journeyed to Senegal to help with a massive ecological and infrastructural greening effort as part of their coursework. The Dakar Greenbelt aims to combat desertification and promote sustainable urban growth.
As part of an undergraduate course, Penn faculty and students curated an Arthur Ross Gallery exhibition of works from the Neumann family’s extensive collection of modern and contemporary art.
The University’s nexus for technology transfer supports researchers in their innovative efforts, from CAR T to mRNA advancements that have dramatically reshaped the world.
